
Company Info
Phone(844) 445-8843
Year Established
2003
Ticker
ALIM
Exchange
NASDAQ
Contacts
Rick EiswirthPresident & CEO
Philip Ashman
President, International Operations
Todd Wood
President, US Operations
Company Description
Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases.